Trial Profile
Efficacy and Safety of Certican (Rm) in Combination With Myfortic (Rm) in Adult Renal Allograft Recipients Following Calcineurin Inhibitor Withdrawal at Week 16 Compared to Patients Who Are Maintained on Tacrolimus and Myfortic (Rm)
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Everolimus (Primary) ; Mycophenolate mofetil (Primary) ; Mycophenolate sodium (Primary) ; Prednisolone; Prednisone; Tacrolimus
- Indications Renal transplant rejection
- Focus Therapeutic Use
- 25 Jul 2011 New trial record